Carregant...
The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics
FDA has launched a Real World Evidence (RWE) Program for using real-world evidence (RWE) to help support new indications for already approved drugs or biologics and postapproval studies. The plan also includes stakeholder engagement efforts, demonstration projects, leadership activities, and develop...
Guardat en:
| Publicat a: | J Diabetes Sci Technol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7196856/ https://ncbi.nlm.nih.gov/pubmed/30862182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296819832661 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|